Logo image of TRZ.CA

TRANSAT A.T. INC (TRZ.CA) Stock Fundamental Analysis

Canada - TSX:TRZ - CA89351T4019 - Common Stock

2.46 CAD
-0.06 (-2.38%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, TRZ scores 2 out of 10 in our fundamental rating. TRZ was compared to 6 industry peers in the Passenger Airlines industry. TRZ may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, TRZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year TRZ has reported negative net income.
In the past year TRZ had a positive cash flow from operations.
In the past 5 years TRZ always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: TRZ reported negative operating cash flow in multiple years.
TRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFTRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With an excellent Return On Assets value of 11.16%, TRZ belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With a Return On Invested Capital value of 4.98%, TRZ perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA 11.16%
ROE N/A
ROIC 4.98%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRZ.CA Yearly ROA, ROE, ROICTRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 8.66%, TRZ belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With a Operating Margin value of 2.32%, TRZ is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
TRZ has a Gross Margin of 50.03%. This is in the better half of the industry: TRZ outperforms 66.67% of its industry peers.
TRZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.32%
PM (TTM) 8.66%
GM 50.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
TRZ.CA Yearly Profit, Operating, Gross MarginsTRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

TRZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, TRZ has more shares outstanding
Compared to 5 years ago, TRZ has more shares outstanding
Compared to 1 year ago, TRZ has a worse debt to assets ratio.
TRZ.CA Yearly Shares OutstandingTRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TRZ.CA Yearly Total Debt VS Total AssetsTRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TRZ has an Altman-Z score of 0.75. This is a bad value and indicates that TRZ is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.75, TRZ is doing worse than 66.67% of the companies in the same industry.
The Debt to FCF ratio of TRZ is 23.89, which is on the high side as it means it would take TRZ, 23.89 years of fcf income to pay off all of its debts.
TRZ has a better Debt to FCF ratio (23.89) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.89
Altman-Z 0.75
ROIC/WACC1.3
WACC3.83%
TRZ.CA Yearly LT Debt VS Equity VS FCFTRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

TRZ has a Current Ratio of 0.70. This is a bad value and indicates that TRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TRZ (0.70) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.67 indicates that TRZ may have some problems paying its short term obligations.
TRZ has a Quick ratio (0.67) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.67
TRZ.CA Yearly Current Assets VS Current LiabilitesTRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TRZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.61%, which is quite impressive.
TRZ shows a small growth in Revenue. In the last year, the Revenue has grown by 4.80%.
The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)63.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%4.09%

3.2 Future

The Earnings Per Share is expected to grow by 27.41% on average over the next years. This is a very strong growth
Based on estimates for the next years, TRZ will show a small growth in Revenue. The Revenue will grow by 3.44% on average per year.
EPS Next Y46.45%
EPS Next 2Y37.83%
EPS Next 3Y27.41%
EPS Next 5YN/A
Revenue Next Year3.74%
Revenue Next 2Y3.9%
Revenue Next 3Y3.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRZ.CA Yearly Revenue VS EstimatesTRZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TRZ.CA Yearly EPS VS EstimatesTRZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRZ. In the last year negative earnings were reported.
Also next year TRZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRZ.CA Price Earnings VS Forward Price EarningsTRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRZ is valued cheaper than 83.33% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TRZ indicates a rather cheap valuation: TRZ is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.51
EV/EBITDA 4
TRZ.CA Per share dataTRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as TRZ's earnings are expected to grow with 27.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.83%
EPS Next 3Y27.41%

0

5. Dividend

5.1 Amount

TRZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRANSAT A.T. INC

TSX:TRZ (10/10/2025, 7:00:00 PM)

2.46

-0.06 (-2.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)09-10 2025-09-10/amc
Earnings (Next)12-18 2025-12-18/amc
Inst Owners16.54%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap99.04M
Analysts49.09
Price Target3.29 (33.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)56.34%
Min EPS beat(2)-0.2%
Max EPS beat(2)112.88%
EPS beat(4)3
Avg EPS beat(4)103.28%
Min EPS beat(4)-0.2%
Max EPS beat(4)290.9%
EPS beat(8)4
Avg EPS beat(8)53.48%
EPS beat(12)8
Avg EPS beat(12)159.65%
EPS beat(16)8
Avg EPS beat(16)116.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.38%
Max Revenue beat(4)3.03%
Revenue beat(8)4
Avg Revenue beat(8)0.12%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)6
Avg Revenue beat(16)-3.93%
PT rev (1m)5.9%
PT rev (3m)5.9%
EPS NQ rev (1m)-62.5%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)-28.18%
EPS NY rev (3m)40.03%
Revenue NQ rev (1m)-8.11%
Revenue NQ rev (3m)-9.44%
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.51
P/OCF 0.61
P/B N/A
P/tB N/A
EV/EBITDA 4
EPS(TTM)-1.39
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)1.63
FCFY66.39%
OCF(TTM)4.06
OCFY164.98%
SpS84.84
BVpS-15.73
TBVpS-16.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.16%
ROE N/A
ROCE 6.91%
ROIC 4.98%
ROICexc 7.23%
ROICexgc 7.41%
OM 2.32%
PM (TTM) 8.66%
GM 50.03%
FCFM 1.93%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
F-Score6
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.89
Debt/EBITDA 4.14
Cap/Depr 39.08%
Cap/Sales 2.86%
Interest Coverage 0.65
Cash Conversion 49.66%
Profit Quality 22.24%
Current Ratio 0.7
Quick Ratio 0.67
Altman-Z 0.75
F-Score6
WACC3.83%
ROIC/WACC1.3
Cap/Depr(3y)38.18%
Cap/Depr(5y)29.63%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
EPS Next Y46.45%
EPS Next 2Y37.83%
EPS Next 3Y27.41%
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%4.09%
Revenue Next Year3.74%
Revenue Next 2Y3.9%
Revenue Next 3Y3.44%
Revenue Next 5YN/A
EBIT growth 1Y329.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year580.43%
EBIT Next 3Y100.75%
EBIT Next 5YN/A
FCF growth 1Y-76.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.63%
OCF growth 3YN/A
OCF growth 5Y-15.21%